Non-neuronal acetylcholine release and its contribution to COPD pathology

Drug Discovery Today: Disease Mechanisms

Volumn 3, Issue 1, 2006, Pages 47-52

  Kummer, Wolfgang ^a   Lips, Katrin S ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CORTICOSTERONE; FLUTICASONE; GLUCOCORTICOID; LOBELINE; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE;

ACETYLCHOLINE RELEASE; ANTIINFLAMMATORY ACTIVITY; BRONCHOSPASM; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; EPITHELIUM CELL; HUMAN; INFLAMMATORY CELL; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER; NONHUMAN; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; REGULATORY MECHANISM; RESPIRATORY AIRFLOW; RESPIRATORY EPITHELIUM; REVIEW;

EID: 33745905337     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2006.02.008     Document Type: Review

References (40)

1. Barnes P.J. Distribution of receptor targets in the lung. Proc. Am. Thorac. Soc. 1 (2004) 345-351
2. Lukas R.J., et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51 (1999) 397-401
3. Elgoyhen A.B., et al. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and chochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. U S A 98 (2001) 3501-3506
4. Proskocil B.J., and Fryer A.D. β2-Agonist and anticholinergic drugs in the treatment of lung disease. Proc. Am. Thorac. Soc. 2 (2005) 305-310
5. Ullao L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov. 4 (2005) 673-684
6. Blanchet M.-R., et al. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am. J. Respir. Crit. Care Med. 169 (2004) 903-909
7. Blanchet M.-R., et al. Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist. Eur. Respir. J. 26 (2005) 21-27
8. Reinheimer T., et al. Glucocorticoids mediate reduction of epithelial acetylcholine content in the airways of rats and humans. Eur. J. Pharmacol. 349 (1998) 277-284
9. Wessler I., et al. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in human. Pharmacol. Ther. 77 (1998) 59-79
10. Wessler I., et al. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. Br. J. Pharmacol. 134 (2001) 951-956
11. Schlereth T., et al. In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin. Br. J. Pharmacol. 7 (2005) 1-5
12. Proskocil B.J., et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 145 (2004) 2498-2506
13. Song P., et al. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 63 (2003) 214-221
14. Adriaensen I., et al. Functional morphology of pulmonary neuroepithelial bodies: extremely complex airway receptors. Anat. Rec. 270A (2003) 25-40
15. Lips K.S., et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am. J. Respir. Cell. Mol. Biol. 33 (2005) 79-88
16. +ATPase. Biol. Cell. 95 (2003) 453-457
17. +-ATPases regulate intracellular pH in human lung microvascular endothelial cells. Biochem. Biophys. Res. Commun. 320 (2004) 1123-1132
18. Heming T.A., and Bidani A. Effects of plasmalemmal V-ATPase activity on plasma membrane potential of resident alveolar macrophages. Lung 181 (2003) 121-125
19. Koepsell H., et al. Organic cation transporters. Rev. Physiol. Biochem. Pharmacol. 150 (2003) 36-90
20. Fischer A., and Hoffmann B. Nitric oxide synthase in neurons and nerve fibres of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am. J. Respir. Crit. Care Med. 154 (1996) 209-216
21. Toews M.L. Synopsis of discussions in session 2. Targeting G-protein-coupled receptors in COPD. Proc. Am. Thorac. Soc. 2 (2005) 311-312
22. Moffatt J.D., et al. Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br. J. Pharmacol. 141 (2004) 1159-1166
23. Fisher J.T., et al. Mice lacking both M2 and M3 muscarinic receptors display airway hyperresponsiveness (AHR) to serotonin. Eur. Respir. J. 26 Suppl. 49 (2005) 714
24. Struckmann N., et al. Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol. Pharmacol. 64 (2003) 1444-1451
25. Undem B.J., and Kollarik M. The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2 (2005) 355-360
26. Butler J.E., et al. Changes in respiratory sensations induced by lobeline after human bilateral lung transplantation. J. Physiol. 534 (2001) 583-593
27. 4 production and neutrophilic inflammation in COPD patients. Allergy 60 (2005) 1361-1369
28. Profita M., et al. Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD. Eur. Respir. J. 26 Suppl. 49 (2005) 121
29. Wessler I.K., and Kirckpatrick C.J. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm. Pharmacol. Ther. 14 (2001) 423-434
30. Lips, K.S. et al. (in press) Expression of the non-neuronal cholinergic system in acute allergic airway disease of rat and mouse. Ann. Anat. (Suppl.)
31. Pfeil U., et al. Expression of the high-affinity choline transporter, CHT1, in the rat trachea. Am. J. Respir. Cell Mol. Biol. 28 (2003) 473-477
32. Dolezal V., et al. Stimuli that induce a cholinergic neuronal phenotype of NG108-15 cells upregulate ChAT and VAChT mRNAs but fail to increase VAChT protein. Brain Res. Bull. 54 (2001) 363-373
33. Kawashima K., and Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune functions. Front. Biosci. 9 (2004) 2063-2085
34. Haberberger R.V., et al. Expression of the cholinergic gene locus in pulmonary arterial endothelial cells. Histochem. Cell Biol. 113 (2000) 379-387
35. Carlisle D.L., et al. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir. Res. 5 (2004) 27
36. Gosens R., et al. Acetylcholine: a novel regulator of airway smooth muscle remodelling?. Eur. J. Pharmacol. 500 (2004) 193-201
37. Roman J., et al. Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling. FASEB J. 18 (2004) 1436-1438
38. Rehan V.K., et al. Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) 667-676
39. Dorion G., et al. Effect of 1,1-dimethylphenyl 1,4-piperazinium on mouse tracheal smooth muscle responsiveness. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) 1139-1145
40. Zimring J.C., et al. Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway. J. Neuroimmunol. 164 (2005) 66-75